Cabergoline Effect on Blood Sugar in Type 2 Diabetics
NCT01459601 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2011-10-25
Summary
Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.
Conditions
- Diabetes Type 2
Interventions
- DRUG
-
Cabergoline
0,5mg per week
Sponsors & Collaborators
-
Mashhad University of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
More Related Trials
-
The Use of Statin in Diabetic Patients Not Known to Have Atherosclerotic Cardiovascular Disease
NCT06676683 ·Status: NOT_YET_RECRUITING
-
Experimental Studies of the Effects of Caffeine on Glucose Regulation
NCT00432887 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Carbohydrase-inhibiting Polyphenols on Glycaemic Response in Vivo
NCT01994135 ·Status: COMPLETED ·Phase: NA
-
The Clinical Effect of Vitamin K Administration in Type 2 Diabetic Patients
NCT04285450 ·Status: COMPLETED ·Phase: NA
-
Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus
NCT02666807 ·Status: COMPLETED ·Phase: NA
-
DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy
NCT04825795 ·Status: COMPLETED
-
Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults
NCT03714438 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients
NCT01241695 ·Status: COMPLETED ·Phase: NA
-
Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion
NCT02397447 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease
NCT02446054 ·Status: COMPLETED ·Phase: NA
-
The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects
NCT02586168 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Zinc in Patients With Type 2 Diabetes
NCT06751823 ·Status: COMPLETED
-
Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance
NCT02621060 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Low Carbohydrate Diet in Reducing Polypharmacy for Patients With Type 2 Diabetes Mellitus
NCT03176056 ·Status: COMPLETED ·Phase: NA
-
Colchicine Has Anti-diabetic Effect
NCT04377321 ·Status: COMPLETED
-
The Effect of DBcare, a Food Supplement on Diabetes Control
NCT00563004 ·Status: COMPLETED ·Phase: NA
-
Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes
NCT01456026 ·Status: COMPLETED ·Phase: NA
-
Trial of Different Dosages' Ge Gen Qin Lian Decoction in the Treatment of Type 2 Diabetes
NCT01219803 ·Status: UNKNOWN ·Phase: NA
-
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
NCT03675360 ·Status: COMPLETED ·Phase: NA
-
Glutathione-rich Foods for Type 2 Diabetes
NCT04386187 ·Status: COMPLETED ·Phase: NA
-
Antioxidant Treatment of Type 2 Diabetes
NCT00609102 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes
NCT04791787 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Products in Subjects With Type 2 Diabetes
NCT02923960 ·Status: COMPLETED ·Phase: NA
-
Gycabiane and Glycemic Control of Prediabetic Subjects
NCT01530685 ·Status: COMPLETED ·Phase: NA
-
The Effects of DPPIs on Cognitive Function of Diabetic Patients
NCT06164535 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4